scispace - formally typeset
M

Mark M. Davis

Researcher at Stanford University

Publications -  623
Citations -  84251

Mark M. Davis is an academic researcher from Stanford University. The author has contributed to research in topics: T cell & T-cell receptor. The author has an hindex of 144, co-authored 581 publications receiving 74358 citations. Previous affiliations of Mark M. Davis include Washington University in St. Louis & University of Chicago.

Papers
More filters
Journal ArticleDOI

How αβ T-cell receptors ‘see’ peptide/MHC complexes

TL;DR: It is found that the V(D)J junction or ‘CDR3' portion of TCRα and β seem most important in contacting peptides bound to MHC molecules, consistent with previous predictions.
Journal ArticleDOI

Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis

TL;DR: A number of recent developments in this technology have made these multimers much easier to make and use in large numbers, and enrichment techniques have provided a greatly increased sensitivity that allows the analysis of the naive T cell repertoire directly.
Journal ArticleDOI

CD4 Augments the Response of a T Cell to Agonist but Not to Antagonist Ligands

TL;DR: Data suggest that CD4 engagement occurs after a TCR-peptide/MHC complex has formed and that it requires a certain minimal half-life of the ternary complex to be fully engaged in signaling.
Journal ArticleDOI

Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases.

TL;DR: In silico quantification of cell proportions from mixed-cell transcriptomics data (deconvolution) requires a reference expression matrix, called basis matrix, and introduces immunoStates, a basis matrix built using 6160 samples with different disease states across 42 microarray platforms that significantly reduces biological and technical biases.